{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:33:15Z","timestamp":1765809195061,"version":"3.48.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100016999","name":"Western Norway University Of Applied Sciences","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016999","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Studies have shown high rates of hypoglycaemia among home-dwelling older people receiving home care services. Hypoglycaemia can lead to severe consequences and in worst case, death. Therefore, knowledge about the factors associated with the occurrence of hypoglycaemia in this patient group is important. This study aimed to investigate the associations between hypoglycaemia and relevant diabetes and age-related factors among individuals with diabetes aged\u2009\u2265\u200965 years who received home care services.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective observational study included data from blinded continuous glucose monitoring to identify hypoglycaemia and glycaemic variability. Further, data from blood tests (HbA1c, serum creatinine), medication lists, and questionnaires on cognitive function, functional status with need of assistance, and nutritional status were collected. Data analysis was performed using Fisher\u2019s exact tests and unadjusted logistic regression analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In total, 56 individuals participated (52% men, median age 82 years). We identified a statistically significant association between hypoglycaemia and glycaemic variability (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). All participants with a coefficient of variation (CV)\u2009\u2265\u200936% had undergone at least one hypoglycaemic event during the study period. Also, participants with CV\u2009\u2265\u200927% had higher risk of hypoglycaemia than those with CV\u2009&lt;\u200927% (OR 5.3, 95% CI 1.6, 17.7). Among the 34 participants with HbA1c\u2009\u2265\u200953 mmol\/mol, 32% experienced hypoglycaemia. In total, 93% were treated with medications that potentially interfered with the effect of their diabetes medications, and 64% were treated with medications that potentially affected their ability to detect symptoms of hypoglycaemia. The associations between hypoglycaemia and cognitive, functional, or nutritional status is uncertain due to limitations in sample size.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study highlights a significant association between glycaemic variability and hypoglycaemia among older home-dwelling adults with diabetes receiving home care services. The prevalence of drug-drug interactions raises concerns about diabetes treatment and emphasise the need for targeted interventions to improve safety and care for this vulnerable group of patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12877-025-06732-9","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:28:28Z","timestamp":1765808908000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hypoglycaemia and its associations with diabetes and age-related factors in older home-dwelling people with diabetes"],"prefix":"10.1186","volume":"25","author":[{"given":"Mari","family":"Fl\u00f8de","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jannicke","family":"Igland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingvild","family":"Hernar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun K.","family":"Sigurdardottir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eirik","family":"S\u00f8fteland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"\u00c5sberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trond Geir","family":"Jenssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Haugstvedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"issue":"10397","key":"6732_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"KL Ong","year":"2023","unstructured":"Ong KL, Stafford LK, McLaughlin SA, Boyko EJ, Vollset SE, Smith AE, et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021. Lancet. 2023;402(10397):203\u201334. https:\/\/doi.org\/10.1016\/S0140-6736(23)01301-6.","journal-title":"Lancet"},{"issue":"1","key":"6732_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/dme.13790","volume":"36","author":"TT Davies","year":"2019","unstructured":"Davies TT, Graue M, Igland J, Tell GS, Birkeland KI, Peyrot M, et al. Diabetes prevalence among older people receiving care at home: associations with symptoms, health status and psychological well-being. Diabet Med. 2019;36(1):96\u2013104. https:\/\/doi.org\/10.1111\/dme.13790.","journal-title":"Diabet Med"},{"issue":"1","key":"6732_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12902-022-01068-6","volume":"22","author":"T Teigland","year":"2022","unstructured":"Teigland T, Igland J, Tell GS, Haltbakk J, Graue M, Fismen A-S, et al. The prevalence and incidence of pharmacologically treated diabetes among older people receiving home care services in Norway 2009\u20132014: a nationwide longitudinal study. BMC Endocr Disord. 2022;22(1):1\u20139. https:\/\/doi.org\/10.1186\/s12902-022-01068-6.","journal-title":"BMC Endocr Disord"},{"key":"6732_CR4","doi-asserted-by":"publisher","DOI":"10.2337\/db18-202-LB","author":"AB Kaiser","year":"2018","unstructured":"Kaiser AB, Zhang N, Der Pluijm WV. Global prevalence of type 2 diabetes over the next ten years (2018\u20132028). Diabetes. 2018. https:\/\/doi.org\/10.2337\/db18-202-LB.","journal-title":"Diabetes"},{"key":"6732_CR5","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee. 13. Older Adults: Standards of Care in Diabetes\u20142025. Diabetes Care. 2024;48(Supplement_1):S266-S82. https:\/\/doi.org\/10.2337\/dc25-S013.","DOI":"10.2337\/dc25-S013"},{"issue":"5","key":"6732_CR6","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1210\/jc.2019-00198","volume":"104","author":"D LeRoith","year":"2019","unstructured":"LeRoith D, Biessels GJ, Braithwaite SS, Casanueva FF, Draznin B, Halter JB, et al. Treatment of diabetes in older adults: an endocrine Society* clinical practice guideline. J Clin Endocrinol Metab. 2019;104(5):1520\u201374. https:\/\/doi.org\/10.1210\/jc.2019-00198.","journal-title":"J Clin Endocrinol Metab"},{"key":"6732_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.571568","volume":"12","author":"K Mattishent","year":"2021","unstructured":"Mattishent K, Loke YK. Meta-analysis: association between hypoglycemia and serious adverse events in older patients treated with glucose-lowering agents. Front Endocrinol. 2021;12:571568. https:\/\/doi.org\/10.3389\/fendo.2021.571568.","journal-title":"Front Endocrinol"},{"issue":"1","key":"6732_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-023-01472-6","volume":"23","author":"M Fl\u00f8de","year":"2023","unstructured":"Fl\u00f8de M, Hermann M, Haugstvedt A, S\u00f8fteland E, Igland J, \u00c5sberg A, et al. High number of hypoglycaemic episodes identified by CGM among home-dwelling older people with diabetes: an observational study in Norway. BMC Endocr Disord. 2023;23(1):218. https:\/\/doi.org\/10.1186\/s12902-023-01472-6.","journal-title":"BMC Endocr Disord"},{"issue":"2","key":"6732_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.pcd.2017.08.002","volume":"12","author":"AH Heald","year":"2018","unstructured":"Heald AH, Anderson SG, Cortes GJ, Cholokova V, Narajos M, Khan A, et al. Hypoglycaemia in the over 75s: understanding the predisposing factors in type 2 diabetes (T2DM). Prim Care Diabetes. 2018;12(2):133\u20138. https:\/\/doi.org\/10.1016\/j.pcd.2017.08.002.","journal-title":"Prim Care Diabetes"},{"issue":"8","key":"6732_CR10","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1210\/jc.2013-1589","volume":"98","author":"RS Weinstock","year":"2013","unstructured":"Weinstock RS, Xing D, Maahs DM, Michels A, Rickels MR, Peters AL, et al. Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D exchange clinic registry. J Clin Endocrinol Metab. 2013;98(8):3411\u20139. https:\/\/doi.org\/10.1210\/jc.2013-1589.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"6732_CR11","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1007\/s00125-018-4668-1","volume":"61","author":"AK Lee","year":"2018","unstructured":"Lee AK, Rawlings AM, Lee CJ, Gross AL, Huang ES, Sharrett AR, et al. Severe hypoglycaemia, mild cognitive impairment, dementia and brain volumes in older adults with type 2 diabetes: the atherosclerosis risk in communities (ARIC) cohort study. Diabetologia. 2018;61(9):1956\u201365. https:\/\/doi.org\/10.1007\/s00125-018-4668-1.","journal-title":"Diabetologia"},{"issue":"4","key":"6732_CR12","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/jppr.1163","volume":"45","author":"B Jafari","year":"2015","unstructured":"Jafari B, Britton ME. Hypoglycaemia in elderly patients with type 2 diabetes mellitus: a review of risk factors, consequences and prevention. J Pharm Pract Res. 2015;45(4):459\u201369. https:\/\/doi.org\/10.1002\/jppr.1163.","journal-title":"J Pharm Pract Res"},{"issue":"9","key":"6732_CR13","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1007\/s40520-022-02165-1","volume":"34","author":"F Remelli","year":"2022","unstructured":"Remelli F, Ceresini MG, Trevisan C, Noale M, Volpato S. Prevalence and impact of polypharmacy in older patients with type 2 diabetes. Aging Clin Exp Res. 2022;34(9):1969\u201383. https:\/\/doi.org\/10.1007\/s40520-022-02165-1.","journal-title":"Aging Clin Exp Res"},{"issue":"10","key":"6732_CR14","doi-asserted-by":"publisher","first-page":"911","DOI":"10.2165\/00002018-200730100-00009","volume":"30","author":"K Johnell","year":"2007","unstructured":"Johnell K, Klarin I. The relationship between number of drugs and potential drug-drug interactions in the elderly. Drug Saf. 2007;30(10):911\u20138. https:\/\/doi.org\/10.2165\/00002018-200730100-00009.","journal-title":"Drug Saf"},{"issue":"8","key":"6732_CR15","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1111\/bcp.14754","volume":"87","author":"C Carnovale","year":"2021","unstructured":"Carnovale C, Gringeri M, Battini V, Mosini G, Invernizzi E, Mazhar F, et al. Beta\u2010blocker\u2010associated hypoglycaemia: new insights from a real\u2010world pharmacovigilance study. Br J Clin Pharmacol. 2021;87(8):3320\u201331. https:\/\/doi.org\/10.1111\/bcp.14754.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"6732_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1161\/HYPERTENSIONAHA.117.09259","volume":"70","author":"T Tsujimoto","year":"2017","unstructured":"Tsujimoto T, Sugiyama T, Shapiro MF, Noda M, Kajio H. Risk of cardiovascular events in patients with diabetes mellitus on \u03b2-blockers. Hypertension. 2017;70(1):103\u201310. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.09259.","journal-title":"Hypertension"},{"issue":"4","key":"6732_CR17","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1161\/HYPERTENSIONAHA.117.09259","volume":"13","author":"B Kovatchev","year":"2019","unstructured":"Kovatchev B, Glycemic, Variability. Risk Factors, Assessment, and control. J Diabetes Sci Technol. 2019;13(4):627\u201335. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.09259.","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"6732_CR18","first-page":"31","volume":"43","author":"C iPro","year":"2018","unstructured":"iPro C. iPro2 continuous glucose monitoring system. US Pharm. 2018;43(5):31\u20132. iPro2 continuous glucose monitoring system.","journal-title":"US Pharm"},{"issue":"6","key":"6732_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2023.101488","volume":"49","author":"L Monnier","year":"2023","unstructured":"Monnier L, Bonnet F, Colette C, Renard E, Owens D. Key indices of glycaemic variability for application in diabetes clinical practice. Diabetes Metab. 2023;49(6):101488. https:\/\/doi.org\/10.1016\/j.diabet.2023.101488.","journal-title":"Diabetes Metab"},{"issue":"19","key":"6732_CR20","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJ\/Moa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, et al. New creatinine-and Cystatin C\u2013based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737\u201349. https:\/\/doi.org\/10.1056\/NEJ\/Moa2102953.","journal-title":"N Engl J Med"},{"issue":"4","key":"6732_CR21","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/jamia\/ocx010","volume":"24","author":"KW Fung","year":"2017","unstructured":"Fung KW, Kapusnik-Uner J, Cunningham J, Higby-Baker S, Bodenreider O. Comparison of three commercial knowledge bases for detection of drug-drug interactions in clinical decision support. J Am Med Inform Assoc. 2017;24(4):806\u201312. https:\/\/doi.org\/10.1093\/jamia\/ocx010.","journal-title":"J Am Med Inform Assoc"},{"issue":"4","key":"6732_CR22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/jamia\/ocx010","volume":"5","author":"R Kheshti","year":"2016","unstructured":"Kheshti R, Aalipour M, Namazi S. A comparison of five common drug\u2013drug interaction software programs regarding accuracy and comprehensiveness. J Res Pharm Pract. 2016;5(4):257\u201363. https:\/\/doi.org\/10.1093\/jamia\/ocx010.","journal-title":"J Res Pharm Pract"},{"key":"6732_CR23","unstructured":"Strobel K, Engedal K, MMSE-NR. Norsk revidert Mini Mental Status Evaluering. Book MMSE-NR, Norsk revidert Mini Mental Status Evaluering Oslo: Nasjonal kompetansetjeneste i aldring og helse. 2008."},{"issue":"3","key":"6732_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189\u201398.","journal-title":"J Psychiatr Res"},{"key":"6732_CR25","unstructured":"Strobel C, Engedal K. Norsk revidert mini mental status evaluering (MMSE-NR). Demensutredning i kommunehelsetjenesten Aldring og helse\u2013Nasjonalt kompetansesenter Helsedirektoratet. 2009."},{"issue":"2","key":"6732_CR26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/psyg.13069","volume":"24","author":"QC Truong","year":"2024","unstructured":"Truong QC, Cervin M, Choo CC, Numbers K, Bentvelzen AC, Kochan NA, et al. Examining the validity of the Mini-Mental state examination (MMSE) and its domains using network analysis. Psychogeriatrics. 2024;24(2):259\u201371. https:\/\/doi.org\/10.1111\/psyg.13069.","journal-title":"Psychogeriatrics"},{"key":"6732_CR27","unstructured":"M\u00f8rk E, Beyrer S, Valdes Haugstveit F, Sundby B. Kommunale helse- og omsorgstjenester. Statistikk om tjenester og tjenestemottakere. 2015."},{"issue":"4","key":"6732_CR28","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1177\/0884533608321132","volume":"23","author":"JM Bauer","year":"2008","unstructured":"Bauer JM, Kaiser MJ, Anthony P, Guigoz Y, Sieber CC. The mini nutritional assessment\u00ae\u2014its history, today\u2019s practice, and future perspectives. Nutr Clin Pract. 2008;23(4):388\u201396. https:\/\/doi.org\/10.1177\/0884533608321132.","journal-title":"Nutr Clin Pract"},{"issue":"6","key":"6732_CR29","first-page":"466","volume":"10","author":"Y Guigoz","year":"2006","unstructured":"Guigoz Y. The mini nutritional assessment (MNA\u00ae) review of the literature-what does it tell us? J Nutr Health Aging. 2006;10(6):466.","journal-title":"J Nutr Health Aging"},{"issue":"4","key":"6732_CR30","doi-asserted-by":"publisher","first-page":"502","DOI":"10.2337\/dc15-2035","volume":"39","author":"B Kovatchev","year":"2016","unstructured":"Kovatchev B, Cobelli C. Glucose variability: timing, risk analysis, and relationship to hypoglycemia in diabetes. Diabetes Care. 2016;39(4):502\u201310. https:\/\/doi.org\/10.2337\/dc15-2035.","journal-title":"Diabetes Care"},{"issue":"6","key":"6732_CR31","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1089\/dia.2022.0006","volume":"24","author":"L Monnier","year":"2022","unstructured":"Monnier L, Colette C, Owens D. Below which threshold of glycemic variability is there a minimal risk of hypoglycemia in people with type 2 diabetes? Diabetes Technol Ther. 2022;24(6):453\u20134. https:\/\/doi.org\/10.1089\/dia.2022.0006.","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"6732_CR32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/jdi.12676","volume":"9","author":"T Ishikawa","year":"2018","unstructured":"Ishikawa T, Koshizaka M, Maezawa Y, Takemoto M, Tokuyama Y, Saito T, et al. Continuous glucose monitoring reveals hypoglycemia risk in elderly patients with type 2 diabetes mellitus. J Diabetes Investig. 2018;9(1):69\u201374. https:\/\/doi.org\/10.1111\/jdi.12676.","journal-title":"J Diabetes Investig"},{"issue":"Supplement1","key":"6732_CR33","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.2337\/dc21-S006","volume":"44","author":"AD Association","year":"2020","unstructured":"Association AD. 6. Glycemic targets: standards of medical care in Diabetes\u20142021. Diabetes Care. 2020;44(Supplement1):S73\u201384. https:\/\/doi.org\/10.2337\/dc21-S006.","journal-title":"Diabetes Care"},{"issue":"8","key":"6732_CR34","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.jdiacomp.2018.05.005","volume":"32","author":"K Mattishent","year":"2018","unstructured":"Mattishent K, Loke Y. Detection of asymptomatic drug-induced hypoglycemia using continuous glucose monitoring in older people\u2013systematic review. J Diabetes Complicat. 2018;32(8):805\u201312. https:\/\/doi.org\/10.1016\/j.jdiacomp.2018.05.005.","journal-title":"J Diabetes Complicat"},{"issue":"11","key":"6732_CR35","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.2337\/dc13-0610","volume":"36","author":"KJ Lipska","year":"2013","unstructured":"Lipska KJ, Warton EM, Huang ES, Moffet HH, Inzucchi SE, Krumholz HM, et al. HbA1c and risk of severe hypoglycemia in type 2 diabetes: the diabetes and aging study. Diabetes Care. 2013;36(11):3535\u201342. https:\/\/doi.org\/10.2337\/dc13-0610.","journal-title":"Diabetes Care"},{"issue":"4","key":"6732_CR36","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1001\/archinternmed.2010.539","volume":"171","author":"MN Munshi","year":"2011","unstructured":"Munshi MN, Segal AR, Suhl E, Staum E, Desrochers L, Sternthal A, et al. Frequent hypoglycemia among elderly patients with poor glycemic control. Arch Intern Med. 2011;171(4):362\u20134. https:\/\/doi.org\/10.1001\/archinternmed.2010.539.","journal-title":"Arch Intern Med"},{"issue":"6","key":"6732_CR37","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S2213-8587(18)30069-X","volume":"6","author":"HJ Florez","year":"2018","unstructured":"Florez HJ. Glycaemic control and glycaemic variability in older people with diabetes. Lancet Diabetes Endocrinol. 2018;6(6):433\u20135. https:\/\/doi.org\/10.1016\/S2213-8587(18)30069-X.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"6732_CR38","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/00325481.2019.1578590","volume":"131","author":"J Freeman","year":"2019","unstructured":"Freeman J. Management of hypoglycemia in older adults with type 2 diabetes. Postgrad Med. 2019;131(4):241\u201350. https:\/\/doi.org\/10.1080\/00325481.2019.1578590.","journal-title":"Postgrad Med"},{"issue":"8","key":"6732_CR39","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42(8):1593\u2013603. https:\/\/doi.org\/10.2337\/dci19-0028.","journal-title":"Diabetes Care"},{"issue":"2","key":"6732_CR40","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1089\/dia.2022.0284","volume":"25","author":"R Bailey","year":"2023","unstructured":"Bailey R, Calhoun P, Bergenstal RM, Beck RW. Assessment of the glucose management indicator using different sampling durations. Diabetes Technol Ther. 2023;25(2):148\u201350. https:\/\/doi.org\/10.1089\/dia.2022.0284.","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"6732_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s40814-020-00754-3","volume":"7","author":"AB Larsen","year":"2021","unstructured":"Larsen AB, Hermann M, Graue M. Continuous glucose monitoring in older people with diabetes receiving home care\u2014a feasibility study. Pilot Feasibility Stud. 2021;7(1):12. https:\/\/doi.org\/10.1186\/s40814-020-00754-3.","journal-title":"Pilot Feasibility Stud"},{"issue":"11","key":"6732_CR42","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-032037","volume":"9","author":"K Mattishent","year":"2019","unstructured":"Mattishent K, Lane K, Salter C, Dhatariya K, May HM, Neupane S, et al. Continuous glucose monitoring in older people with diabetes and memory problems: a mixed-methods feasibility study in the UK. BMJ Open. 2019;9(11):e032037. https:\/\/doi.org\/10.1136\/bmjopen-2019-032037.","journal-title":"BMJ Open"},{"key":"6732_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12877-017-0621-2","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17:1\u201310. https:\/\/doi.org\/10.1186\/s12877-017-0621-2.","journal-title":"BMC Geriatr"},{"issue":"4","key":"6732_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.621","volume":"8","author":"L AL-Musawe","year":"2020","unstructured":"AL-Musawe L, Torre C, Guerreiro JP, Rodrigues AT, Raposo JF, Mota\u2010Filipe H, et al. Polypharmacy, potentially serious clinically relevant drug\u2010drug interactions, and inappropriate medicines in elderly people with type 2 diabetes and their impact on quality of life. Pharmacol Res Perspect. 2020;8(4):e00621. https:\/\/doi.org\/10.1002\/prp2.621.","journal-title":"Pharmacol Res Perspect"},{"key":"6732_CR45","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s00125-021-05394-7","volume":"64","author":"A H\u00f6hn","year":"2021","unstructured":"H\u00f6hn A, Jeyam A, Caparrotta TM, McGurnaghan SJ, O\u2019Reilly JE, Blackbourn LA, et al. The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetes. Diabetologia. 2021;64:1309\u201319. https:\/\/doi.org\/10.1007\/s00125-021-05394-7.","journal-title":"Diabetologia"},{"issue":"2","key":"6732_CR46","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/dom.12587","volume":"18","author":"K Mattishent","year":"2016","unstructured":"Mattishent K, Loke YK. Bi-directional interaction between hypoglycaemia and cognitive impairment in elderly patients treated with glucose-lowering agents: a systematic review and meta-analysis. Diabetes Obes Metab. 2016;18(2):135\u201341. https:\/\/doi.org\/10.1111\/dom.12587.","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"6732_CR47","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2337\/dc13-1384","volume":"37","author":"I Feinkohl","year":"2014","unstructured":"Feinkohl I, Aung PP, Keller M, Robertson CM, Morling JR, McLachlan S, et al. Severe hypoglycemia and cognitive decline in older people with type 2 diabetes: the Edinburgh type 2 diabetes study. Diabetes Care. 2014;37(2):507\u201315. https:\/\/doi.org\/10.2337\/dc13-1384.","journal-title":"Diabetes Care"},{"issue":"15","key":"6732_CR48","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1056\/NEJMoa1003795","volume":"363","author":"S Zoungas","year":"2010","unstructured":"Zoungas S, Patel A, Chalmers J, De Galan BE, Li Q, Billot L, et al. Severe hypoglycemia and risks of vascular events and death. N Engl J Med. 2010;363(15):1410\u20138. https:\/\/doi.org\/10.1056\/NEJMoa1003795.","journal-title":"N Engl J Med"},{"issue":"4","key":"6732_CR49","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/07435800.2020.1792921","volume":"45","author":"W Kaewput","year":"2020","unstructured":"Kaewput W, Thongprayoon C, Rangsin R, Bathini T, Torres-Ortiz A, Mao MA, et al. Incidence and risk factors associated with outpatient hypoglycemia in patients with type 2 diabetes and chronic kidney disease: a nationwide study. Endocr Res. 2020;45(4):217\u201325. https:\/\/doi.org\/10.1080\/07435800.2020.1792921.","journal-title":"Endocr Res"},{"issue":"5","key":"6732_CR50","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.2337\/dc12-1408","volume":"36","author":"J-S Yun","year":"2013","unstructured":"Yun J-S, Ko S-H, Ko S-H, Song K-H, Ahn Y-B, Yoon K-H, et al. Presence of macroalbuminuria predicts severe hypoglycemia in patients with type 2 diabetes: a 10-year follow-up study. Diabetes Care. 2013;36(5):1283\u20139. https:\/\/doi.org\/10.2337\/dc12-1408.","journal-title":"Diabetes Care"},{"issue":"8","key":"6732_CR51","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1111\/dom.14051","volume":"22","author":"B Runesson","year":"2020","unstructured":"Runesson B, Xu Y, Qureshi AR, Lindholm B, Barany P, Elinder CG, et al. Association between reduced kidney function and incident hypoglycaemia in people with diabetes: the Stockholm creatinine measurements (SCREAM) project. Diabetes Obes Metab. 2020;22(8):1425\u201335. https:\/\/doi.org\/10.1111\/dom.14051.","journal-title":"Diabetes Obes Metab"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-025-06732-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-025-06732-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-025-06732-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:28:31Z","timestamp":1765808911000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12877-025-06732-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6732"],"URL":"https:\/\/doi.org\/10.1186\/s12877-025-06732-9","relation":{},"ISSN":["1471-2318"],"issn-type":[{"type":"electronic","value":"1471-2318"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"19 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Regional Committee for Medical and Health Research Ethics (REK South-East) (2018\/512). This research project was conducted in accordance with the Helsinki Declaration. Each participant was informed about the study protocol and provided a written and informed consent form before taking part in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Mari Fl\u00f8de has received lecture fees from Novo Nordisk and Abbott. Ingvild Hernar has received lecture fees from Novo Nordisk. Trond Geir Jenssen has received lecture fees from Novo Nordisk, Eli Lilly, Astra Zeneca and Boehringen Ingelheim. Eirik S\u00f8fteland has received lecture fees from Novo Nordisk, Boehringen Ingelheim, Astra Zeneca, Otsuko Pharma, Eli Lilly and Sanof Aventis. Anne Haugstvedt has received lecture fees from Novo Nordisk and Abbott. Other authors declared no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1020"}}